Albert Hong-Jae Kim MD PhD
Brain & Spinal Tumor, Pituitary Surgery, Skull Base
Director, The Brain Tumor Center, August A Busch Jr Professor of Neurosurgery Washington University School of Medicine Siteman Cancer Center
Join to view full profile
4500 Forest Park AveDept Neurological Surgery Ste 1BSt. Louis, MO 63108
Phone+1 314-362-3577
Fax+1 314-362-2107
Dr. Kim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Albert Kim is a neurosurgeon based in St. Louis, MO, specializing in brain tumors, pituitary surgery, and skull base surgery, and is Director of The Brain Tumor Center at Siteman Cancer Center / WashU Medicine. He completed a fellowship in cerebrovascular and skull base surgery at the University of Miami and a residency in neurological surgery at Mass General Brigham. His clinical interests include glioblastoma and other gliomas, vestibular schwannomas, pituitary tumors, and meningiomas, using open and endoscopic approaches. He has contributed to over 170 publications on topics related to brain tumors.
Education & Training
University of Miami/Jackson Health SystemFellowship, Cerebrovascular & Skull Base Surgery, 2010 - 2011
Mass General Brigham/Brigham and Women's Hospital/Children's HospitalResidency, Neurological Surgery, 2004 - 2010- Brigham and Womens HospitalInternship, Transitional Year, 2003 - 2004
New York University School of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2021 - 2029
FL State Medical License 2025 - 2028
IA State Medical License 2025 - 2028
TN State Medical License 2025 - 2028
IN State Medical License 2025 - 2027
KS State Medical License 2025 - 2027
KY State Medical License 2025 - 2027
American Board of Neurological Surgery Neurological Surgery- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Optical microscopy predictions of focal recurrence in glioblastoma.Sanjeev Herr, Niels Olshausen, Melike Pekmezci, Jasleen Kaur, Youssef Sibih
Science Advances. 2026-09-25 - Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.Eric C Leuthardt, Veronica Chiang, Constantinos G Hadjipanayis, Patrick Landazuri, Dimitris G Placantonakis
Journal of Clinical Oncology. 2026-09-20 - Adamantinomatous craniopharyngioma: outcomes from a US multicenter registry cohort (RAPID consortium study).Yuki Shinya, Sandhya R Palit, Maria Peris Celda, Andrew S Little, Mark A Pacult
Journal of Neurosurgery. 2026-09-01
Journal Articles
- Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched ...Cosette Dechant, Gene H Barnett, Andreas Seas, Eric C Leuthardt, Kevin O Juarez, Hanna Kemeny, Peter E Fecci, Manmeet S Ahluwalia, Mayur Sharma, Thomas L Beaumont, Alb..., Neurosurgery
Press Mentions
Researchers Make Glioblastoma Cells Visible to Attacking Immune CellsNovember 8th, 2024- Researchers Make Glioblastoma Cells Visible to Attacking Immune CellsNovember 7th, 2024
- Study Increases Understanding of What Makes Multiply Recurrent Meningiomas a Most Aggressive Form of Brain TumorOctober 24th, 2024
Grant Support
- Mechanisms of SOX2 Regulation in GlioblastomaWASHINGTON UNIVERSITY2022–2027
- Mechanisms of SOX2 Regulation in GlioblastomaWASHINGTON UNIVERSITY2022–2027
- Mechanisms of SOX2 Regulation in GlioblastomaWASHINGTON UNIVERSITY2022–2027
- Mechanisms of SOX2 Regulation in GlioblastomaWASHINGTON UNIVERSITY2022–2027
- NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy ResistanceWASHINGTON UNIVERSITY2019–2025
Professional Memberships
- Member
- Member
- Southern Neurosurgical SocietyMember
- Society for Neuro-OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: